Black Clawson Company appeals the district court’s grant of summary judgment in favor of the defendants. We reverse and remand.
I.
Black Clawson Company, Inc., an Ohio corporation with its principal place of business in New York, is a licensee of certain intellectual property' owned by a German corporation, Pagendarm Technologie GmbH. Black Clawson manufactures coating, drying, and moisturizing equipment for paper, film, and textiles. The license agreement was entered into on May 14, 1996, and grants Black Clawson the exclusive rights to use the proprietary information in its manufacturing business in North America.
Maschinenfabrik Max Kroenert GmbH & Co. (MMK), a German corporation with its principal place of business in Germany, is in the same business as Black Clawson, Kroenert Corporation, a Delaware corporation with its principal place of business in Iowa, is a wholly owned subsidiary of MMK that solicits orders in the United States for products to be manufactured by MMK. Klaus Dieter Reinhardt is a director of Kroenert and MMK, and is a citizen and resident of Germany.
Certain former employees of Pagendarm allegedly stole the licensed technology from Pagendarm in Germany in late 1995 and created Kroenert and MMK to market in the United States products manufactured with the technology, directly interfering with Black Clawson’s property rights in the technology. The theft was known to Pagendarm and Black Clawson when they entered into the license agreement. The license agreement transfers the exclusive right within the United States to use the licensed technology, including any and all inventions covered by the agreement, and to manufacture, use, sell, or lease any and all products covered by the agreement. The only rights withheld from Black Clawson are the rights to disclose proprietary information to third parties and to sub-license to third parties *762 without Pagendarm’s consent: The agreement contains a choice of law provision stating that it would be interpreted, and any disputes arising out of it would be resolved, according to New York law. It further provided that neither party can obligate or bind the other to third parties in any way.
In 1997, Black Clawson filed the present case against the defendants in federal district court in Iowa, alleging that Reinhardt, along with others, created the defendant corporations for the purpose of unfairly competing with Black Clawson in the United States and seeking damages and injunctive relief under the Racketeer Influenced and Corrupt Organizations Act (RICO), 18 U.S.C. §§ 1961-1968, the Lan-ham Act, 15 U.S.C. § 1051 et seq., the Paris Convention for the Protection of Industrial Property (through 15 U.S.C. §§ 1126(b) and 1126(i) (1994)), and Iowa law. The state law causes of action include conversion, misappropriation of trade secrets, conspiracy, unjust enrichment, tortious interference with existing contractual rights, and unfair competition.
Also in 1997, a German corporation with a similar exclusive license from Pagen-darm covering Europe, Pagendarm BTT, GmbH (BTT), filed suit in a German court against MMK and its German subsidiary (the German defendants) for the misappropriation and improper use in Europe of the technology. Pagendarm intervened in the German lawsuit so that all causes of action arising out of conduct occurring in Germany could be resolved together. On July 28, 1998, Pagendarm and BTT entered into a settlement agreement with the German defendants resolving and dismissing the German litigation with prejudice. As a part of that settlement, Pagendarm waived all claims against the German defendants to which it was or would become entitled concerning the technology at issue here. The settlement recited that it applied for the benefit of all shareholders, directors, employees, and affiliates of the German defendants. The German defendants attempted to induce Black Clawson to dismiss the American litigation and to intervene in the German lawsuit for the purposes of resolving and disposing of all claims against all of the defendants relating to the misappropriation and improper use of the technology through the German settlement and release. Black Clawson refused to dismiss its lawsuit in the United States and did not participate in the German litigation.
The relevant clause of the settlement agreement states: “Plaintiff waives, also for the past and future, all claims against Defendants to which it is or will be entitled concerning the [technology licensed to Black Clawson] ... and rights pertaining thereto, and particularly [the specific conduct upon which Pagendarm and its European licensee brought suit].” The district court interpreted this language to release the defendants from liability to Black Clawson, concluding that Pagendarm could have asserted any claim held by Black Clawson. The court also found that Pa-gendarm’s settlement unambiguously released the defendants from any further liability to Pagendarm or any other party related to or arising out of the defendants’ acquisition and use of the technology any where in the world. Comparing the present controversy to a dispute between a licensee of a patent and a third party infringer,
see
35 U.S.C. §§ 271, 281 (1994
&
Supp. IV 1998);
Biosyntec, Inc. v. Baxter Healthcare Corp.,
*763 II.
We review the grant of summary judgment de novo.
Williams v. Kelso,
The district court granted summary judgment based on the principle of res judicata, or claim preclusion. Preclusion doctrines are employed to conserve judicial resources and protect parties from “the expense and vexation” of relitigating claims and issues that have been previously adjudicated.
Tyus v. Schoemehl,
Foreign adjudication of an issue may preclude its relitigation in our courts. A foreign judgment is recognized, enforced, and given preclusive effect by a court of this country if the court finds five factors to be present.
Shen v. Leo A. Daly Co.,
The parties do not dispute that the German court properly adjudicated the claim that was before it. The factors set out in Shen are satisfied, and the claims resolved in the German case will preclude Black Clawson’s suit if the general rules as set out in Costner are satisfied. The only issue in dispute is the scope of the judgment in the German case, i.e., whether it extinguished claims based upon defendants’ conduct in the United States and whether Pagendarm represented or was in privity with Black Clawson such that Black Clawson should be bound by that case.
Because the German court entered judgment accepting the settlement agreement and dismissing the case with prejudice, the settlement agreement has the effect of a final judgment on the merits of the case.
Larken, Inc. v. Wray,
Whether a party adequately represents a non-party such that the party can be considered the virtual representative of the other is a fact-intensive inquiry based on several factors.
Tyus,
Although Black Clawson and Pagendarm have a close business relationship with respect to this technology, their interests with respect to its use in the United States are not identical. The license agreement transfers the exclusive right within the United States to use the licensed technology, including the right to practice any and all inventions covered by the agreement and to manufacture, use, sell, or lease any and all products covered by the agreement. The only rights specifically withheld from Black Clawson are the rights to disclose the proprietary information to third parties and to sub-license to third parties without Pagendarm’s consent. Black Clawson possessed all substantial rights to the technology, including the right to bring suit for interference with the technology and Black Clawson’s rights to it.
See Agrashell, Inc. v. Hammons Prods. Co.,
Because Pagendarm has assigned its rights by contract, the only party who would be harmed by the defendants’ improper importation and use of the technology in the United States is Black Clawson. Pagendarm has already received value for the use of the technology in the United States, and will remain in precisely the same position whether Black Clawson alone uses the technology in this country or MMK competes with it. Thus, Pagen-darm’s and Black Clawson’s interests are divergent, and Pagendarm had little practical incentive to assert Black Clawson’s rights in the German litigation. Accordingly, we conclude that Black Clawson was not in privity with Pagendarm and that Pagendarm did not provide Black Clawson with virtual representation in the German litigation. The settlement in Germany therefore has no res judicata effect in the present action.
In ruling that Pagendarm’s release discharged Black Clawson’s claims as licensee, the district court relied on the proposition that a release by a patentee for infringement by a stranger precludes any subsequent action by a licensee arising out of the infringement.
See Biosyntec,
Even if Black Clawson’s rights in the technology were treated as analogous to a patent, Black Clawson’s claims would still not be not precluded by Pagendarm’s release in Germany. Title to a patent is assignable, and an assignee holds the same rights that the original patentee had.
See Prima Tek II,
Pagendarm granted to Black Clawson all substantial rights to the technology for the entire country. The acts committed by the defendants occurred in the United States during the effective period of the license and caused injury to Black Claw-son. Therefore, as an assignee of the licensed technology, Black Clawson would have standing to bring its own claims against the defendants independent of Pa-gendarm. Thus, Pagendarm could not have released the defendants from claims or causes of action to which it was not entitled.
The summary judgment is reversed, and the case is remanded for further proceedings not inconsistent with this opinion.
